Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 13;21(20):7533.
doi: 10.3390/ijms21207533.

Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms

Affiliations
Review

Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms

Anam Anjum et al. Int J Mol Sci. .

Abstract

Spinal cord injury (SCI) is a destructive neurological and pathological state that causes major motor, sensory and autonomic dysfunctions. Its pathophysiology comprises acute and chronic phases and incorporates a cascade of destructive events such as ischemia, oxidative stress, inflammatory events, apoptotic pathways and locomotor dysfunctions. Many therapeutic strategies have been proposed to overcome neurodegenerative events and reduce secondary neuronal damage. Efforts have also been devoted in developing neuroprotective and neuro-regenerative therapies that promote neuronal recovery and outcome. Although varying degrees of success have been achieved, curative accomplishment is still elusive probably due to the complex healing and protective mechanisms involved. Thus, current understanding in this area must be assessed to formulate appropriate treatment modalities to improve SCI recovery. This review aims to promote the understanding of SCI pathophysiology, interrelated or interlinked multimolecular interactions and various methods of neuronal recovery i.e., neuroprotective, immunomodulatory and neuro-regenerative pathways and relevant approaches.

Keywords: neuro-regeneration; neurodegeneration; neuroprotection; primary injury; secondary injury; spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Spinal cord injury (SCI) (a) phases of SCI, (b) sub-classification of secondary injury depending on duration of injury and (c) pathophysiological events according to SCI phases.
Figure 2
Figure 2
Pathophysiology, clinical manifestations, and phases of SCI.
Figure 3
Figure 3
Stages of axon degeneration, (A) acute injury responses, (B) acute axonal degeneration (AAD) and (C) Wallerian degeneration.
Figure 4
Figure 4
(A) Healthy spinal cord and (B) an injured spinal cord with three lesion compartments, showing inner non-viable small lesion compartment, compact astrocyte core, and perilesion perimeters with multicellular and multi-molecular components (astrocytes, neurons, macrophages, microglia, NG2-OPC, fibrocytes, oligodendrocytes, fibroblast, nerve cells and activated astrocytes) regulating gliosis (gliosis scar formation) post SCI.
Figure 5
Figure 5
Molecular interactions balancing inflammatory responses, debris clearance and phagocytosis regulators following SCI with left showing hydrophobic intercellular molecular interactions controlling harmful signal while right cycle reflect neuro-inflammatory molecular interaction controlling phagocytosis while center portion show multimolecular interactions to clear cellular phagocytic debris.
Figure 6
Figure 6
Neuroprotective pathways and different neuroprotective approaches with centre portion showing neuroprotective pathways (i) neurotransmitter agonist/antagonist, (ii) channel blockers, (iii) anti-oxidative pathways, (iv) apoptotic pathway (v) herbal and natural agents, (vi) cellular and genetic agents, while various agents acting on specific pathways are shown by pointed arrows.
Figure 7
Figure 7
Apoptotic pathway (i) intrinsic pathway and (ii) extrinsic pathway with anti-apoptotic inhibitors, i.e., calpain and caspase that act on specific target molecule and retard apoptosis.
Figure 8
Figure 8
Immuno-modulatory (neuro-inflammatory) pathway following spinal cord injury and specific immuno-modulatory agents.
Figure 9
Figure 9
Neuroregenerative pathway (RhoA/Rho and Rock pathway) and underlying neuroregenerative approaches (i) enhancement of remyelination and (ii) enhancement of neuronal and axonal regeneration strategies.

Similar articles

Cited by

References

    1. Khorasanizadeh M., Yousefifard M., Eskian M., Lu Y., Chalangari M., Harrop J.S., Rahimi-Movaghar V. Neurological recovery following traumatic spinal cord injury: A systematic review and meta-analysis. J. Neurosurg. 2019;30:683–699. doi: 10.3171/2018.10.SPINE18802. - DOI - PubMed
    1. Katoh H., Yokota K., Fehlings M.G. Regeneration of spinal cord connectivity through stem cell transplantation and biomaterial scaffolds. Front. Cell. Neurosci. 2019;13:248. doi: 10.3389/fncel.2019.00248. - DOI - PMC - PubMed
    1. Htwe O., Hussain R.I., Naicker A.S. Challenges in Managing Severe Lower Limb Spasticity Associated with Bilateral Hip Joints Subluxation. Eur. J. Gen. Med. 2016;13:165–167.
    1. Ohnmar H., Das S., Naicker A.S. An interesting case of Autonomic Dysreflexia. Clin. Ter. 2009;160:371. - PubMed
    1. O’Shea T.M., Burda J.E., Sofroniew M.V. Cell biology of spinal cord injury and repair. J. Clin. Investig. 2017;127:3259–3270. doi: 10.1172/JCI90608. - DOI - PMC - PubMed